X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DIVIS LABORATORIES - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DIVIS LABORATORIES PFIZER/
DIVIS LABORATORIES
 
P/E (TTM) x 28.8 31.3 91.9% View Chart
P/BV x 4.6 5.4 84.4% View Chart
Dividend Yield % 0.7 0.9 77.5%  

Financials

 PFIZER   DIVIS LABORATORIES
EQUITY SHARE DATA
    PFIZER
Mar-16
DIVIS LABORATORIES
Mar-17
PFIZER/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,7241,222 222.9%   
Low Rs1,611784 205.5%   
Sales per share (Unadj.) Rs440.9153.1 288.0%  
Earnings per share (Unadj.) Rs48.739.9 121.9%  
Cash flow per share (Unadj.) Rs75.844.6 169.9%  
Dividends per share (Unadj.) Rs15.0010.00 150.0%  
Dividend yield (eoy) %0.71.0 69.4%  
Book value per share (Unadj.) Rs462.9201.8 229.4%  
Shares outstanding (eoy) m45.75265.47 17.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.96.6 75.0%   
Avg P/E ratio x44.525.1 177.3%  
P/CF ratio (eoy) x28.622.5 127.2%  
Price / Book Value ratio x4.75.0 94.2%  
Dividend payout %30.825.0 123.0%   
Avg Mkt Cap Rs m99,163266,266 37.2%   
No. of employees `0002.99.7 29.7%   
Total wages/salary Rs m2,7584,687 58.8%   
Avg. sales/employee Rs Th6,981.74,175.0 167.2%   
Avg. wages/employee Rs Th954.5481.5 198.2%   
Avg. net profit/employee Rs Th771.11,089.3 70.8%   
INCOME DATA
Net Sales Rs m20,17040,643 49.6%  
Other income Rs m857749 114.5%   
Total revenues Rs m21,02841,392 50.8%   
Gross profit Rs m4,31014,460 29.8%  
Depreciation Rs m1,2391,233 100.4%   
Interest Rs m523 23.0%   
Profit before tax Rs m3,92313,953 28.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7943,349 53.6%   
Profit after tax Rs m2,22810,604 21.0%  
Gross profit margin %21.435.6 60.1%  
Effective tax rate %45.724.0 190.5%   
Net profit margin %11.026.1 42.3%  
BALANCE SHEET DATA
Current assets Rs m16,29940,105 40.6%   
Current liabilities Rs m7,5946,595 115.2%   
Net working cap to sales %43.282.5 52.3%  
Current ratio x2.16.1 35.3%  
Inventory Days Days65119 55.1%  
Debtors Days Days2681 31.9%  
Net fixed assets Rs m8,62219,995 43.1%   
Share capital Rs m458531 86.2%   
"Free" reserves Rs m20,72253,043 39.1%   
Net worth Rs m21,18053,574 39.5%   
Long term debt Rs m250-   
Total assets Rs m29,13761,585 47.3%  
Interest coverage x755.5618.4 122.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.7 104.9%   
Return on assets %7.717.3 44.4%  
Return on equity %10.519.8 53.1%  
Return on capital %19.026.1 72.8%  
Exports to sales %0.10-   
Imports to sales %17.525.2 69.2%   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,52610,259 34.4%   
Fx inflow Rs m5235,384 0.1%   
Fx outflow Rs m14010,399 1.3%   
Net fx Rs m-8824,985 -0.4%   
CASH FLOW
From Operations Rs m3,43611,493 29.9%  
From Investments Rs m-6,991-11,372 61.5%  
From Financial Activity Rs m-619-93 664.7%  
Net Cashflow Rs m-4,17428 -14,695.4%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 11.8 63.6%  
FIIs % 4.9 19.0 25.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.2 137.8%  
Shareholders   85,207 31,796 268.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 300 Points; Tata Steel Up 3.5%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels. Sectoral indices are trading on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 23, 2018 03:26 PM

TRACK PFIZER

PFIZER - PIRAMAL ENTERPRISES COMPARISON

COMPARE PFIZER WITH

MARKET STATS